Westchester Capital Management (New York)’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Hold
248,852
0.12% 135
2025
Q4
$2.61M Hold
248,852
0.11% 128
2025
Q3
$2.57M Buy
+248,852
New +$2.57M 0.12% 129

Other funds holding TDAC

Westchester Capital Management (New York)'s TDAC Position: Q1 2026 in Review

Westchester Capital Management (New York) held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 248,852 shares worth $2.63M. The position accounts for 0.12% of the portfolio, ranked #135.

Westchester Capital Management (New York) first reported a position in TDAC in Q3 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Westchester Capital Management (New York) held 248,852 shares of Translational Development Acquisition Corp worth $2.63M as of Q1 2026.
  • Westchester Capital Management (New York) left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up 0.12% of Westchester Capital Management (New York)'s portfolio in Q1 2026, its #135 holding.
  • Westchester Capital Management (New York) first reported a position in Translational Development Acquisition Corp in Q3 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.